Oragenics (OGEN) Change in Acquisitions & Divestments (2016 - 2026)
Oragenics' (OGEN) quarterly Change in Acquisitions & Divestments came in at $4.0 million in Q1 2026, up 2100.0% on a QoQ basis from -$200000.0 in Q4 2016.
Oragenics (OGEN) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Oragenics (OGEN) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Sep 2016 was $1.0 million (changed N/A YoY) and the FY2016 annual result came in at $250000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments improved to $4.0 million in Q1 2026, from -$200000.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $4.0 million in Q1 2026 to a low of $4.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2016 | -200,000.00 |
| Dec 31, 2016 | -200,000.00 |
| Sep 30, 2016 | 1.00 Mn |
| Sep 30, 2016 | 1.00 Mn |